论文部分内容阅读
目的:研究分析稽留流产使用雌激素联合抗早孕药物和米非司酮联合米索前列醇治疗的临床疗效差异性。方法:根据我院接收的孕周低于13周的妇产科患者200例来进行研究分析,将这些患者分组为A、B两组,A组患者接受米非司酮联合米索前列醇治疗,B组患者使用戊酸雌二醇治疗,三天后增加米非司酮联合米索前列醇治疗。结果:经过治疗后B组完全排出率明显高于A组,清宫率低于A组。结论:B组的清宫率比较低,米非司酮配伍米索前列醇联合戊酸雌二醇治疗稽留流产的效果比较好,患者再次情感几率低,因此临床中是一种可行、可靠的稽留流产治疗方法。
Objective: To study the clinical efficacy of estrogen combined with anti-early pregnancy and mifepristone plus misoprostol in missed abortion. Methods: According to our hospital received gestational age less than 13 weeks of obstetrics and gynecology patients 200 cases were analyzed, these patients were grouped into A, B two groups, patients in group A received mifepristone combined with misoprostol , B group patients with estradiol valerate treatment, three days after the increase of mifepristone combined with misoprostol treatment. Results: After treatment, the complete discharge rate of group B was significantly higher than that of group A, and the rate of clearance was lower than that of group A. Conclusions: The rate of cesarean section in group B is relatively low. Mifepristone combined with misoprostol and estradiol valerate is more effective in treating missed abortion, and the probability of re-seizure in patients is lower again, so it is feasible and reliable in clinical practice. Abortion treatment.